Fig. 3From: Subcutaneous immunoglobulin in primary immunodeficiency – impact of training and infusion characteristics on patient-reported outcomesA continuum of health outcomes: an adaptation to subcutaneous immunoglobulin self-infusions in primary immune deficiency. Conceptual framework adapted from Wilson IB, et al. JAMA. 1995;273(1):59–65. QOL, quality of life; SCIG, subcutaneous immunoglobulinBack to article page